Statement Of Cash Flows [Abstract]

Biofrontera AG - Filing #6520750

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for decrease (increase) in other current assets
36,000 EUR
30,000 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets
912,000 EUR
981,000 EUR
Cash flows from (used in) financing activities [abstract]
Payments for share issue costs
0 EUR
64,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.